deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02140151

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (PREVENT)

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (AMD) in Vulnerable Eyes With Nonexudative AMD Trial: A Multicenter, Prospectively Randomized, Masked and Controlled, Interventional Investigator Sponsored Phase I/II Study

Sponsor: Southern California Desert Retina Consultants, MC

Conditions Age-related Macular Degeneration
Interventions Ranibizumab 0.5mg
Updated 8 times since 2017 Last updated: Aug 23, 2022 Started: Sep 17, 2014 Primary completion: Jul 9, 2020 Completion: Jul 9, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02140151, this PHASE1/PHASE2 trial focuses on Age-related Macular Degeneration and remains completed. Sponsored by Southern California Desert Retina Consultants, MC, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotRecruiting~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotUnknown Status~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshotUnknown Status~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

    Status: Unknown Status → Completed

  4. Jan 2021 — Sep 2022 [monthly]

    Unknown Status PHASE1_PHASE2

  5. Jan 2019 — Jan 2021 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE1_PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Southern California Desert Retina Consultants, MC
Data source: Southern California Desert Retina Consultants, MC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations